Here are the details and DD updates
My friend met Mark Schena who is president of Arrayit. I had already posted the details of my last
call with Rene and it was very positive, seems that after that lot of people tried to call them, may have pissed them off. Please do not call..
Here are the key points
- Protein Microarray demand is exploding and they are generating lots of revenue now
- The real turnaround started in 2015 end. ArrayIt had many frustrating years of evolution, now they are all geared towards solid growth
- The demand for their product was not picking up and company was trying to get foothold for long time, lot of money went into the research and technology changes. Things started changing in past 1 1/2 years
- Improved microplating standards, many health science labs started using ArrayIt stuff
- Now they have good demand, they may expand in the future. He even joked, Do you think this facility is cheap ?. It is expensive real estate area.
- Yes it's expensive real estate in middle of silicon valley next to Google and Apples - They seem to be self sufficient now - No more dilution
- They are at par with Illumina and Affy as far tech is concerned - Both billion + market cap companies, Iluumina is giant
- Plan to move out of over the counter exchange (The worse exchange to be on with market manipulator taking you for ride daily) by 2017 year end or early 2018 - That's may be the main reason for audit (Please do not get hung of Audit exact time, they are in transition phase now
and focus has been filling order backlogs that are expanding rapidly, they are pushing hard to wrap up the audit. So it's coming. They are doing it, since these are old ghosts for arrayit for many years -did not give exact date though when it will complete, but sooner
- Mark feels based on current revenue market cap needs to be guess what minimum 100 million - key thing based on revenue, although we don't know numbers..(My guess they are generating decent amount of revenue if we are talking 100 million market cap)
- He was even ridiculing the current market cap saying - deeply undervalued ( that means revenues are getting bigger and this is deeply undervalued play, feel this should not be in OTCBB. I know many biotechs in silicon valley for years)
- Their technology is now at par with Illumina and Affy - Lot more cost effective due to small sampling size, as small as finger nail, others have larger sample size
- The new technology is proving on one diseases, but can be applied to 6000 diseases, that's where they want to expand - Many diseases (The parkison's disease twitter feed may be the latest indicator)
- Technology maturity - He said there were lot of logistics issues earlier, third party vendors misteps, we resolved all tech issues
- Big advantages over cost effectiveness - sample sizing and better microplating standards
- Revenue is good - they do not not need to dump shares (you can see NO DILUTION happening with this stock for many months - That is clear proof )
- 20 years of research helped, technology has matured
- 2017 is going to one the best year ahead - massive potential to grow
- They also own ArrayIT Diagnosrtics Inc in Houston - That is helping them a lot now as company expands on many disease fronts - That's another important clue - This is really large company to be on over the counter of not for all those misteps -( GO VISIT !!!! if you want to know the size).
- 2013 they made mistake of huge dilution, meanwhile they spent lot of money on technology, stock crashed - that's all paying off now - revenues are exploding - (It's clear from Twitter feed)
- Their plan is to list on Nasdaq (They feel based on their range of solutions, similar companies in silicon valley - they want to be on Nasdaq, hence cleaning the books and doing it thoroughly, taking longer due to that. They feel they don't deserve to be on over the counter anymore based on the growth ahead, company is generating lot of revenue and can attract bigger money after going to Nasdaq and clearing Audit stuff
- They feel there is nothing that will prevent them from being the next Illumina in Microarray. The technology advances they have done are finally paying off after long 20 years
- They can do both DNA and Protein Microarray ! that's big - Protein is more popular in diseases prediction
- PR will start after audit
Most of the info he said is public, may not be seen in the PR since there was no PR. People who have visited ArrayIt in the past know about it
The growth seen now is new stuff and it's the main game changer 2017 onward.
I bet this will be north of 20 cents if not dollar - That is my most conservative price now. Do DD, do not watch stock price closely up and down and decide fate of the stock.BIOTECH stocks are not for trading. They are for investment. My strategy had been to buy the UNDERVALUED biotech gem and sit on it, do nothing - check after few months..This will leave many OTCBB stock in the dust based on fundamentals alone. It just needs insight and conviction, that happens only after DD
Above all - Visit the company, take appointment and then I bet you will want to buy all the shares of this float at these ridiculous prices..You need to see forest beyond tree..as they say and to see forest you need to look beyond daily fluctuations and not equate that with the fundamentals of a company.
I myself used to consider this as PND stock..yes back in 2015. However I have done considerable research on microarray technolgies an d firmly believe we are on the forefront of genetic evolution and these guys are well poised. I don't care about technicals anymore like everyone does with OTCBB stocks.
I am in this stock because I see NO DILUTION !!! NO TOXIC DUMPS for months and months. Great fundamentals Or I would have disappeared by now even if the fundamentals are great if I see any dilution. I closely watch dilution, they don't seem to need cash to unload shares on us like many OTCBB do and revenues are growing or you would have seen massive dumping and volume.
BTW this is just 0.007 stock, not 0.17 or 0.7..I get surpised and the board here makes it look like 10 cents stock..LOL. Unlike many MJ stocks with zero revenue, billions of shares, 300+ million market cap, hype and hoopla, this is real company with solid revenue and tiny market cap - think !
I am excited about 2017 for sure ..and 2018 will really make this one big..
All my opinion..IMO !
Take it or leave it
This is not my recommendation to buy or sell, do your due diligence, may be visit them, take appointment. No one can beat your own DD. Don't make decisions based on what people post here
good luck to all
NOTE Please sticky this !
You can remove the earlier one